NORTH AMERICAN VACCINE (NVX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NORTH AMERICAN VACCINE (NVX)

NVX 1.510

-3.8%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: andy harrison who wrote (9)	3/6/1997 7:50:00 PM
From: Tom Stone	of 21

I agree that recent weakness was probably not caused by Goldman conf on vaccines. However, I don't think it is "short noise". I believe it is just weak holders that are not used to NVX historically. As you know, they have habitually missed the dates everyone expected of them for years and this is just another one. THE GOOD thing about it is - they have always ultimately come throught with the goods as expected. It is just they seem to take longer than anyone expects. I think they will receive approval but the delay has caused analyst(s) to revise 1997 earnings downward according to First Call. Now 52 cents for 97. However, that is probably the number for the second half and 1998 earnings look great.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next